pyrithione has been researched along with paclitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldassare, J; Bastow, M; Klein, C; Kriedt, CL; Shah, M | 1 |
1 other study(ies) available for pyrithione and paclitaxel
Article | Year |
---|---|
Zinc is a potential therapeutic for chemoresistant ovarian cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cisplatin; Cyclin A; Cyclin D; Cyclin E; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Female; Humans; Ovarian Neoplasms; Paclitaxel; Pyridines; Thiones; Trace Elements; Zinc | 2011 |